South Coast Investors II, LLC – Trademark Portfolio
Entity Type: 16
South Coast Investors II, LLC holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 43 (Hotels & Restaurants) — 6 filings in this category. The portfolio also extends into Class 25 (Clothing) across 4 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include INN AT THE MISSION. The owner is based in San Juan Capistrano, CA.
31866 Camino Capistrano
San Juan Capistrano, CA 92675
Showing of trademarks Trademarks
Trademark Classifications
South Coast Investors II, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does South Coast Investors II, LLC have?
South Coast Investors II, LLC has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 abandoned, 1 cancelled.
What trademark classes does South Coast Investors II, LLC file in?
South Coast Investors II, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 43 (Hotels & Restaurants), Class 25 (Clothing), Class 44 (Medical Services), Class 35 (Advertising & Business). Class 43 covers services for providing food and drink; temporary accommodation.
What are South Coast Investors II, LLC's most well-known trademarks?
South Coast Investors II, LLC's registered trademark portfolio includes well-known marks such as INN AT THE MISSION. These are among 5 currently registered trademarks in the portfolio.
What is South Coast Investors II, LLC's trademark registration success rate?
South Coast Investors II, LLC has a 56% trademark registration rate, with 5 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.